Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Mol Nutr Food Res ; 63(23): e1900626, 2019 12.
Artículo en Inglés | MEDLINE | ID: mdl-31574574

RESUMEN

SCOPE: Obesity is a chronic condition resulting in excessive fat accumulation in adipose tissues. Adipose tissue is now considered as an immune organ, at the crossroads between metabolism and immunity. Thus, this study investigates the effects of adzuki beans on obesity and gut microbiota in high fat diet-induced mice. METHODS AND RESULTS: In this study, adzuki bean hot water extract (AWE) is determined to have the most significant anti-adipogenic effect; it is able to inhibit lipid accumulation in 3T3-L1 adipocytes and reduces body weight and adipose tissue weight in a dose-dependent manner. AWE treatment also decreases M1-polarized adipose tissue macrophages (ATMs) while inducing M2-polarized ATMs. The number and size of fat vacuoles in liver lesions are significantly reduced, indicating that AWE could ameliorate steatosis in high fat diet-induced mice. The results also demonstrate that AWE-treated groups inhibit adipogenesis via activating the Wnt/ß-catenin pathway and reduce peroxisome proliferator-activated receptor gamma and CCAAT/enhancer binding proteins α expression. Moreover, the studies confirm that AWE decreases obesity through modulating gut microbiota. CONCLUSION: The results demonstrate that AWE supplementation ameliorates high fat diet-induced obesity and gut microbiota composition and suggests that AWE may have the potential to be developed into a functional food to improve metabolic disorders.


Asunto(s)
Fármacos Antiobesidad/farmacología , Microbioma Gastrointestinal/efectos de los fármacos , Macrófagos/efectos de los fármacos , Extractos Vegetales/farmacología , Vigna , Células 3T3-L1 , Adipogénesis/efectos de los fármacos , Animales , Polaridad Celular/efectos de los fármacos , Dieta Alta en Grasa , Metabolismo de los Lípidos/efectos de los fármacos , Lípidos/sangre , Macrófagos/fisiología , Masculino , Ratones , Ratones Endogámicos C57BL , Vía de Señalización Wnt/efectos de los fármacos
2.
Mol Nutr Food Res ; 63(20): e1900514, 2019 10.
Artículo en Inglés | MEDLINE | ID: mdl-31368236

RESUMEN

SCOPE: A gut-microbiota-dependent metabolite of L-carnitine, trimethylamine-N-oxide (TMAO), has been recently discovered as an independent and dose-dependent risk factor for cardiovascular disease (CVD). This study aims to investigate the effects of pterostilbene on reducing TMAO formation and on decreasing vascular inflammation in carnitine-feeding mice. METHODS AND RESULTS: C57BL/6 mice are treated with 1.3% carnitine in drinking water with or without pterostilbene supplementation. Using LC-MS/MS, the result shows that mice treated with 1.3% carnitine only significantly increased the plasma TMAO and pterostilbene supplementation group can reverse it. Additionally, pterostilbene decreases hepatic flavin monooxygenase 3 (FMO3) mRNA levels compared to carnitine only group. It appears that pterostilbene can alter host physiology and create an intestinal microenvironment favorable for certain gut microbiota. Gut microbiota analysis reveals that pterostilbene increases the abundance of Bacteroides. Further, pterostilbene decreases mRNA levels of vascular inflammatory markers tumor necrosis factor-α (TNF-α), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin). CONCLUSION: These data suggest that amelioration of carnitine-induced vascular inflammation after consumption of pterostilbene is partially mediated via modulation of gut microbiota composition and hepatic enzyme FMO3 gene expression.


Asunto(s)
Microbioma Gastrointestinal/fisiología , Metilaminas/metabolismo , Estilbenos/farmacología , Vasculitis/prevención & control , Animales , Carnitina/toxicidad , Femenino , Ratones , Ratones Endogámicos C57BL , Oxidación-Reducción , Oxigenasas/genética , Factor de Necrosis Tumoral alfa/genética
3.
J Agric Food Chem ; 67(28): 7869-7879, 2019 Jul 17.
Artículo en Inglés | MEDLINE | ID: mdl-31287296

RESUMEN

Carnitine, a dietary quaternary amine mainly from red meat, is metabolized to trimethylamine (TMA) by gut microbiota and subsequently oxidized to trimethylamine-N-oxide (TMAO) by host hepatic enzymes, flavin monooxygenases (FMOs). The objective of this study aims to investigate the effects of flavonoids from oolong tea and citrus peels on reducing TMAO formation and protecting vascular inflammation in carnitine-feeding mice. The results showed that mice treated with 1.3% carnitine in drinking water significantly (p < 0.05) increased the plasma levels of TMAO compared to control group, whereas the plasma TMAO was remarkedly reduced by flavonoids used. Meanwhile, these dietary phenolic compounds significantly (p < 0.05) decreased hepatic FMO3 mRNA levels compared to carnitine only group. Additionally, oolong tea extract decreased mRNA levels of vascular inflammatory markers such as tissue necrosis factor-alpha (TNF-α), vascular cell adhesion molecule-1 (VCAM-1) and E-selectin. Polymethoxyflavones significantly lowered the expression of VCAM-1 and showed a decreasing trend in TNF-α and E-selectin mRNA expression compared to the carnitine group. Genus-level analysis of the gut microbiota in the cecum showed that these dietary phenolic compounds induced an increase in the relative abundances of Bacteroides. Oolong tea extract-treated group up-regulated Lactobacillus genus, compared to the carnitine only group. Administration of polymethoxyflavones increased Akkermansia in mice.


Asunto(s)
Aterosclerosis/tratamiento farmacológico , Aterosclerosis/metabolismo , Camellia sinensis/química , Carnitina/metabolismo , Citrus/química , Flavonas/administración & dosificación , Extractos Vegetales/administración & dosificación , Animales , Aterosclerosis/genética , Aterosclerosis/microbiología , Bacterias/clasificación , Bacterias/genética , Bacterias/aislamiento & purificación , Bacterias/metabolismo , Biotransformación/efectos de los fármacos , Femenino , Flavonas/análisis , Microbioma Gastrointestinal/efectos de los fármacos , Tracto Gastrointestinal/metabolismo , Tracto Gastrointestinal/microbiología , Humanos , Metilaminas/metabolismo , Ratones , Ratones Endogámicos C57BL , Extractos Vegetales/análisis , Factor de Necrosis Tumoral alfa/genética , Factor de Necrosis Tumoral alfa/metabolismo , Molécula 1 de Adhesión Celular Vascular/genética , Molécula 1 de Adhesión Celular Vascular/metabolismo
4.
Food Funct ; 9(6): 3363-3373, 2018 Jun 20.
Artículo en Inglés | MEDLINE | ID: mdl-29855643

RESUMEN

Polymethoxyflavones (PMFs) and hydroxyl PMFs (HOPMFs) are mainly found in citrus peel and have shown anti-obesity potential in in vitro and in vivo studies. Herein, we have investigated the anti-obesity effects of two citrus peel extracts obtained via supercritical fluid extraction: PMF A, with a lower content of PMFs and HOPMFs, and PMF B, with a higher content of PMFs and HOPMFs. PMF A and PMF B were administered orally for 16 weeks to mice with high fat diet (HFD)-induced obesity. The results showed that PMF B decreased the lipid content more statistically significantly (p < 0.05) than PMF A in 3T3-L1 preadipocytes, reduced the adipocyte size, decreased the adipose tissue weight and alleviated the total body weight in the HFD mice. Both PMF A and PMF B reduced the adipocyte size in the perigonadal fat by markedly decreasing the levels of lipid droplets (LD) and perilipin 1 protein and Sterol regulatory element binding protein 1 (SREBP-1) expression. Compared to the case of the HFD group, PMF B altered the gut microbiota by increasing Prevotella and decreasing rc4-4 bacteria. The change in the composition of gut microbiota, the community of symbiotic and pathogenic microorganisms, may determine the metabolic health and be responsible for the anti-obesity mechanism. Our results indicate that the citrus peel extracts decrease lipid accumulation both in vivo and in vitro and should be considered for the management of overweight and obesity conditions.


Asunto(s)
Bacterias/efectos de los fármacos , Citrus/química , Microbioma Gastrointestinal/efectos de los fármacos , Obesidad/tratamiento farmacológico , Obesidad/microbiología , Extractos Vegetales/administración & dosificación , Células 3T3-L1 , Adipocitos/efectos de los fármacos , Adipocitos/metabolismo , Animales , Bacterias/clasificación , Bacterias/genética , Bacterias/aislamiento & purificación , Dieta Alta en Grasa/efectos adversos , Humanos , Masculino , Ratones , Ratones Endogámicos C57BL , Obesidad/etiología , Obesidad/metabolismo , PPAR gamma/genética , PPAR gamma/metabolismo , Extractos Vegetales/química , Proteína 1 de Unión a los Elementos Reguladores de Esteroles/genética , Proteína 1 de Unión a los Elementos Reguladores de Esteroles/metabolismo
5.
J Complement Integr Med ; 14(3)2017 May 12.
Artículo en Inglés | MEDLINE | ID: mdl-28889732

RESUMEN

Background Immunity and Longevity Methods A water extract of Curcuma longa (L.) [vern. Turmeric] roots (TurmericImmune™) standardized for a minimum 20 % of turmeric polysaccharides ukonan A, B, C and D was evaluated for its biological properties in in vitro tissue culture studies. Results The water extract of turmeric (TurP) exhibited induced-nitric oxide (NO) production in RAW264.7 macrophages. These results suggested the immunomodulatory effects of TurP. In addition, the polysaccharides up-regulated function of telomerase reverse transcriptase (TERT) equally to the phenolic compound from turmeric, curcumin. Conclusions The ukonan family of polysaccharides may assist in promoting cellular immune responses, tissue repair and lifespan by enhancing immune response and telomere function.


Asunto(s)
Curcuma , Hepatocitos/efectos de los fármacos , Macrófagos/efectos de los fármacos , Extractos Vegetales/farmacología , Raíces de Plantas , Telomerasa/metabolismo , Regulación hacia Arriba/efectos de los fármacos , Animales , Biomarcadores/metabolismo , Hepatocitos/enzimología , Hepatocitos/inmunología , Macrófagos/metabolismo , Ratones , Óxido Nítrico/metabolismo , Células RAW 264.7 , Ratas , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Regulación hacia Arriba/inmunología , Agua
6.
Mol Nutr Food Res ; 61(11)2017 11.
Artículo en Inglés | MEDLINE | ID: mdl-28643888

RESUMEN

SCOPE: SlimTrym® is a formulated product composed of citrus polymethoxyflavones (PMFs), green tea extract, and lychee extract. We investigated the effect of dietary SlimTrym® on diet-induced obesity and associated non-alcoholic fatty liver disease (NAFLD) in mice. METHODS AND RESULTS: Male C57BL/6 mice were fed a normal diet (ND), high fat diet (HFD) or HFD containing 0.1% or 0.5% SlimTrym® for 16 weeks. Dietary SlimTrym® significantly reduced weight gain and relative perigonadal, retroperitoneal, mesenteric fat weight as well as the size of adipocyte in HFD-fed mice. SlimTrym® supplementation also effectively diminished hepatic steatosis and the serum levels of glutamate oxaloacetate transaminase (GOT), glutamate pyruvate transaminase (GPT), triacylglycerol (TG), and total cholesterol (TCHO). Down-regulation of peroxisome proliferator-activated receptor (PPAR)γ, sterol regulatory element-binding protein (SREBP)-1, and the activation of AMP-activated protein kinase (AMPK) signaling by SlimTrym® in both adipose tissue and liver may be responsible for the observed anti-obesity effects. CONCLUSION: SlimTrym® supplementation potentially diminished diet-induced obesity and hepatic steatosis via regulating AMPK signaling and molecules involved in lipid metabolism.


Asunto(s)
Camellia sinensis/química , Citrus/química , Suplementos Dietéticos , Litchi/química , Enfermedad del Hígado Graso no Alcohólico/prevención & control , Obesidad/prevención & control , Extractos Vegetales/uso terapéutico , Adipogénesis , Animales , Fármacos Antiobesidad/administración & dosificación , Fármacos Antiobesidad/análisis , Fármacos Antiobesidad/química , Fármacos Antiobesidad/uso terapéutico , Biomarcadores/sangre , Biomarcadores/metabolismo , Dieta Alta en Grasa/efectos adversos , Suplementos Dietéticos/análisis , Etnofarmacología , Flavonas/administración & dosificación , Flavonas/análisis , Flavonas/química , Flavonas/uso terapéutico , Manipulación de Alimentos , Frutas/química , Masculino , Metilación , Ratones Endogámicos C57BL , Enfermedad del Hígado Graso no Alcohólico/sangre , Enfermedad del Hígado Graso no Alcohólico/etiología , Enfermedad del Hígado Graso no Alcohólico/metabolismo , Obesidad/sangre , Obesidad/etiología , Obesidad/metabolismo , Oxidación-Reducción , Extractos Vegetales/administración & dosificación , Hojas de la Planta/química , Polifenoles/administración & dosificación , Polifenoles/análisis , Polifenoles/química , Polifenoles/uso terapéutico , Taiwán
7.
J Med Food ; 19(7): 663-9, 2016 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-27200471

RESUMEN

Circulatory markers of low-grade inflammation such as tumor necrosis factor-alpha (TNF-α), interleukin-1 alpha (IL-1α), and interleukin-1 beta (IL-1ß) positively correlate with endothelial damage, atheroma formation, cardiovascular disease, and aging. The natural vitamin K2-menaquinone-7 (MK-7) added to the cell culture of human monocyte-derived macrophages (hMDMs) at the same time as toll-like receptor (TLR) agonists did not influence the production of TNF-α. When the cells were pretreated up to 6 h with MK-7 before treatment with TLR agonists, MK-7 did not inhibit significantly the production of TNF-α after the TLR activation. However, 30 h pretreatment of hMDMs with at least 10 µM of MK-7 effectively and dose dependently inhibited the proinflammatory function of hMDMs. Pretreatment of hMDMs with 10 µM of MK-7 for 30 h resulted in 20% inhibition of TNF-α production after lipopolysaccharide (LPS) activation (P < .05) and 43% inhibition after macrophage-activating lipopeptide (MALP) activation (P < .001). Pathogen-associated molecular pattern (PMPP) activation was inhibited by 20% with MK-7 pretreatment; however, this inhibition was not statistically significant. The 30 h pretreatment of a THP-1-differentiated monocyte cell line with MK-7 resulted in a dose-dependent downregulation of TNFα, IL-1α, and IL-1ß gene expression as evaluated by RNA semiquantitative reverse transcription polymerase chain reaction (RT-PCR). MK-7 is able to modulate immune and inflammatory reactions in the dose-response inhibition of TNF-α, IL-1α, and IL-1ß gene expression and protein production by the healthy hMDMs in vitro.


Asunto(s)
Interleucina-1alfa/antagonistas & inhibidores , Interleucina-1beta/antagonistas & inhibidores , Macrófagos/efectos de los fármacos , Receptores Toll-Like/agonistas , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Vitamina K 2/análogos & derivados , Antiinflamatorios , Línea Celular , Expresión Génica/efectos de los fármacos , Humanos , Interleucina-1alfa/genética , Interleucina-1beta/genética , Lipopolisacáridos/farmacología , Factor de Necrosis Tumoral alfa/genética , Vitamina K 2/farmacología
8.
Biofactors ; 41(5): 301-13, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26453173

RESUMEN

Recent increasing attention in research of polymethoxyflavones (PMFs) from Citrus genus because of their wide range of biological properties has been reported in various studies. Hydroxylated PMFs are unique flavones and recognized as the methoxy group of PMFs that is substituted for hydroxyl one. Hydroxylated PMFs are naturally existed in citrus peel and other plants as well as occurred as metabolites of their PMFs counterparts. Several in vitro and in vivo studies have documented the chemopreventive effects of hydroxylated PMFs including anti-cancer, anti-inflammation, anti-atherosclerosis, and neuroprotection. They function to regulate cell death, proliferation, differentiation, repair, and metabolism through acting on modulation of signaling cascade, gene transcription, and protein function and enzyme activity. The mechanisms of action of hydroxylated PMFs in disease chemoprevention depend on their structure, the number, and position of hydroxyl group. Although the efficacy of hydroxylated PMFs in chemoprevention and the oral bioavailability requires further investigation, they still provide great promise for improving human health. This review highlights the recent published data of hydroxylated PMFs with chemopreventive potential and the underlying mechanism involved.


Asunto(s)
Flavonas/farmacología , Animales , Antiinflamatorios/farmacología , Anticarcinógenos/farmacología , Citrus sinensis/química , Humanos , Neoplasias/metabolismo , Neoplasias/prevención & control , Extractos Vegetales/farmacología
9.
Food Funct ; 5(1): 12-7, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-24220621

RESUMEN

Chemoprevention is a relatively new and promising strategy to prevent human degenerative diseases, including cancer, and is defined as the use of natural dietary compounds and/or synthetic substances to block, inhibit, reverse, or retard the progress of human diseases. Tetrahydrocurcumin (THC) is a major metabolite of curcumin (extracted from the roots of the Curcuma longa Linn). THC has been demonstrated to prevent oxidative stress and inflammation, to act against neurodegeneration, and to possess anti-cancer activity. In this review, we summarize the current knowledge and underlying molecular mechanisms of the chemopreventative activities of THC and its potential effects on the development of various human diseases.


Asunto(s)
Curcuma/metabolismo , Curcumina/análogos & derivados , Neoplasias/prevención & control , Extractos Vegetales/metabolismo , Animales , Curcumina/metabolismo , Dietoterapia , Humanos , Neoplasias/metabolismo
10.
Mol Nutr Food Res ; 55(1): 32-45, 2011 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-21207511

RESUMEN

Colorectal cancer is one of the major causes of cancer-related mortality in both men and women worldwide. This review focuses on preventing the initiation and promotion of neoplastic growth in colorectal cancer, particularly with natural dietary compounds. Chemoprevention is defined as the use of natural dietary compounds and/or synthetic substances that can delay, prevent, or even reverse the development of adenomas, as well as the progression from adenoma to carcinoma. The molecular mechanisms of their chemopreventive action are associated with the modulation of signaling cascades, gene expressions involved in the regulation of cell proliferation, differentiation, and apoptosis and the suppression of chronic inflammation, metastasis, and angiogenesis. Here, we summarize the currently known targets and signaling pathways whereby natural dietary compounds interfere with the development of colorectal cancer, and thus providing evidence for these substances in colonic cancer chemopreventive action.


Asunto(s)
Quimioprevención , Neoplasias Colorrectales/dietoterapia , Neoplasias Colorrectales/prevención & control , Dieta , Anticarcinógenos/uso terapéutico , Apoptosis , Carotenoides/uso terapéutico , Diferenciación Celular , Proliferación Celular , Ácidos Grasos Omega-3/uso terapéutico , Flavonoides/uso terapéutico , Humanos , Inflamación/dietoterapia , Inflamación/prevención & control , Estilo de Vida , Proantocianidinas/uso terapéutico , Transducción de Señal , Esfingolípidos/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA